{"id":242964,"date":"2026-09-11T10:06:31","date_gmt":"2026-09-11T04:36:31","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=242964"},"modified":"2026-09-11T10:06:31","modified_gmt":"2026-09-11T04:36:31","slug":"why-cipla-share-price-fall-today-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-cipla-share-price-fall-today-2026\/","title":{"rendered":"Cipla (CIPLA) Share Price Falls 2.16% Today as Stock Slips to Rs 1,350.25"},"content":{"rendered":"<div class=\"univest-blue-summary\" style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:12px 16px;margin:0 0 18px 0;font-style:italic;\"><em><a href=\"https:\/\/univest.in\/stocks\/cipla\/cipla-ltd-share-price-today\">Cipla (CIPLA)<\/a>share price fell to Rs 1,350.25 today, down 2.16% from the previous close. Market cap was Rs 1,10,515.04 crore.<\/em><\/div>\n<p style=\"margin-top:0!important;\">Cipla Share Price was at Rs 1,350.25 on 11 September 2026 at 9:52:59 AM IST, down Rs 29.75 or 2.16% for the day, taking the Large Cap pharmaceutical company\u2019s market capitalisation to Rs 1,10,515.04 crore. The stock is in focus because the decline appeared early in the session and kept the price close to the day\u2019s low.<\/p>\n<p>The supplied data confirms the price event, but it does not establish a company-specific catalyst for why the stock is falling today. What the numbers do show is a clear intraday decline from the previous close of Rs 1,380, with the stock opening at Rs 1,370.05, touching the same Rs 1,370.05 as the day\u2019s high, and then slipping to Rs 1,348.95. That pattern indicates weakness from the opening print rather than a late-session swing.<\/p>\n<p>For investors tracking the stock, the broader context is valuation and profitability. Cipla trades at a P\/E ratio of 33.08 and a P\/B ratio of 3.17, while return ratios stand at ROE of 11.83% and ROCE of 16%. EPS is Rs 41.72, book value per share is Rs 435.18 and dividend yield is 0.94%.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/why-cipla-share-price-fall-today-2026\/#Cipla_CIPLA_Share_Price_Today_Price_Action_Analysis\" title=\"Cipla (CIPLA) Share Price Today: Price Action Analysis\">Cipla (CIPLA) Share Price Today: Price Action Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/why-cipla-share-price-fall-today-2026\/#Cipla_CIPLA_Fundamental_Analysis\" title=\"Cipla (CIPLA) Fundamental Analysis\">Cipla (CIPLA) Fundamental Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/why-cipla-share-price-fall-today-2026\/#Sector_and_Industry_Context\" title=\"Sector and Industry Context\">Sector and Industry Context<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/why-cipla-share-price-fall-today-2026\/#Peer_Comparison\" title=\"Peer Comparison\">Peer Comparison<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/why-cipla-share-price-fall-today-2026\/#Why_Investors_Are_Watching_Cipla\" title=\"Why Investors Are Watching Cipla\">Why Investors Are Watching Cipla<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/why-cipla-share-price-fall-today-2026\/#About_Cipla\" title=\"About Cipla\">About Cipla<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/why-cipla-share-price-fall-today-2026\/#Track_Cipla_Share_Price_on_Univest\" title=\"Track Cipla Share Price on Univest\">Track Cipla Share Price on Univest<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/why-cipla-share-price-fall-today-2026\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/why-cipla-share-price-fall-today-2026\/#Why_is_Cipla_Share_Price_falling_today\" title=\"Why is Cipla Share Price falling today?\">Why is Cipla Share Price falling today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/why-cipla-share-price-fall-today-2026\/#What_is_Cipla_Share_Price_Today\" title=\"What is Cipla Share Price Today?\">What is Cipla Share Price Today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/why-cipla-share-price-fall-today-2026\/#What_does_todays_price_action_show_for_Cipla\" title=\"What does today\u2019s price action show for Cipla?\">What does today\u2019s price action show for Cipla?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/why-cipla-share-price-fall-today-2026\/#Is_Cipla_a_Large_Cap_stock\" title=\"Is Cipla a Large Cap stock?\">Is Cipla a Large Cap stock?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/why-cipla-share-price-fall-today-2026\/#What_valuation_ratios_are_investors_tracking_for_Cipla\" title=\"What valuation ratios are investors tracking for Cipla?\">What valuation ratios are investors tracking for Cipla?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/why-cipla-share-price-fall-today-2026\/#How_profitable_is_Cipla_compared_with_its_industry\" title=\"How profitable is Cipla compared with its industry?\">How profitable is Cipla compared with its industry?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/why-cipla-share-price-fall-today-2026\/#What_do_EPS_book_value_and_dividend_yield_show_for_Cipla\" title=\"What do EPS, book value and dividend yield show for Cipla?\">What do EPS, book value and dividend yield show for Cipla?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/why-cipla-share-price-fall-today-2026\/#How_does_Cipla_compare_with_pharma_peers_on_valuation\" title=\"How does Cipla compare with pharma peers on valuation?\">How does Cipla compare with pharma peers on valuation?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/why-cipla-share-price-fall-today-2026\/#How_does_Cipla_compare_with_peers_on_return_ratios\" title=\"How does Cipla compare with peers on return ratios?\">How does Cipla compare with peers on return ratios?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/why-cipla-share-price-fall-today-2026\/#What_should_investors_monitor_next_in_Cipla_stock\" title=\"What should investors monitor next in Cipla stock?\">What should investors monitor next in Cipla stock?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Cipla_CIPLA_Share_Price_Today_Price_Action_Analysis\"><\/span><strong>Cipla (CIPLA) Share Price Today: Price Action Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,350.25<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,380<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Move<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">-Rs 29.75 (-2.16%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,370.05<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,370.05<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,348.95<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Turnover<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 0.57 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,10,515.04 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Cap Category<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Large Cap<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Cipla Share Price Today reflects a weak opening-to-low structure, with the stock failing to move above its opening level and staying under the previous close through the morning session. Turnover stood at Rs 0.57 crore.<\/p>\n<p>In absolute terms, the stock fell Rs 29.75 from Rs 1,380 to Rs 1,350.25. The session began at Rs 1,370.05, which was also the day\u2019s high, and the price later eased to a low of Rs 1,348.95. When a stock opens below the previous close, fails to recover above the opening mark, and trades near the low, it usually signals a soft intraday tone.<\/p>\n<p>Because Cipla is a Large Cap stock with a market cap of Rs 1,10,515.04 crore, even a 2.16% move attracts attention. The verified takeaway is straightforward: the stock weakened early, remained below Rs 1,380, and stayed close to the lower end of the day\u2019s range.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Cipla_CIPLA_Fundamental_Analysis\"><\/span><strong>Cipla (CIPLA) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,10,515.04 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">33.08x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3.17x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.83%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">16%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>EPS<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 41.72<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Book Value Per Share<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 435.18<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Dividend Yield<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0.94%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Cipla\u2019s fundamentals place it among the larger names in Healthcare and Pharmaceuticals &amp; Drugs, while valuation and return ratios look broadly near industry norms rather than at an extreme.<\/p>\n<p>At a market capitalisation of Rs 1,10,515.04 crore, Cipla remains one of the larger names in its space. The stock trades at a P\/E ratio of 33.08 and a P\/B ratio of 3.17. EPS stands at Rs 41.72, book value per share is Rs 435.18 and dividend yield is 0.94%.<\/p>\n<p>Profitability metrics are steady but not the strongest within the peer group. ROE is 11.83%, exactly in line with the industry median of 11.83% and slightly above the industry average of 11.22%. ROCE of 16% is stronger than the industry median of 13.68% and average of 13.71%, suggesting better-than-typical capital efficiency for the broader group.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Industry<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Pharmaceuticals &amp; Drugs<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same industry<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">33.08x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">32.73x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">49.1x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3.4x to 701.57x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3.17x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3.06x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">4.42x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.83%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.83%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.22%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">16%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.68%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.71%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,10,515.04 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 750.93 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 14,206.91 crore<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>The sector data places Cipla in a large and valuation-diverse Pharmaceuticals &amp; Drugs universe. Within the same industry benchmark of 200 companies, its valuation sits close to the median on both earnings and book value multiples, while ROCE is above the typical industry level.<\/p>\n<p>In the same-industry benchmark, the P\/E dataset covers 169 companies, with a median of 32.73, an average of 49.1, and a range from 3.4 to 701.57. Cipla\u2019s P\/E of 33.08 is slightly above the median but well below the average. Its P\/B of 3.17 is also just above the median of 3.06 and below the average of 4.42.<\/p>\n<p>On profitability, ROE matches the median exactly at 11.83% and is above the average of 11.22%, while ROCE of 16% is above both the median of 13.68% and the average of 13.71%. Market-cap data across 200 companies shows a median of Rs 750.93 crore and an average of Rs 14,206.91 crore, compared with Cipla\u2019s Rs 1,10,515.04 crore. That confirms the company is much larger than the typical industry constituent.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/sunpharma\/sun-pharmaceutical-industries-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Sun Pharmaceutical Industries<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">SUNPHARMA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4,48,315.74<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">36.98<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">5.17<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14.85<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.11<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><strong>Divi&#39;s Laboratories<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">DIVISLAB<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,51,737.22<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">85.36<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14.14<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16.19<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.51<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/torntpharm\/torrent-pharmaceuticals-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Torrent Pharmaceuticals<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">TORNTPHARM<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,87,593.62<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">85.95<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">20.89<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">26.76<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.27<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/zyduslife\/zydus-lifesciences-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Zydus Lifesciences<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">ZYDUSLIFE<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,12,618.18<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">24.71<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4.14<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.69<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.39<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/lauruslabs\/laurus-labs-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Laurus Labs<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">LAURUSLABS<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,04,455.86<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">95.67<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">18.55<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">18.31<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">18.2<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Against major listed peers, Cipla appears moderate on valuation but less aggressive on profitability. Its P\/E of 33.08 is below Sun Pharmaceutical Industries at 36.98, well below Divi&#8217;s Laboratories at 85.36, Torrent Pharmaceuticals at 85.95 and Laurus Labs at 95.67, but above Zydus Lifesciences at 24.71.<\/p>\n<p>Market-cap comparison shows Cipla at Rs 1,10,515.04 crore, smaller than Sun Pharma, Divi&#8217;s and Torrent, but close to Zydus at Rs 1,12,618.18 crore and above Laurus Labs at Rs 1,04,455.86 crore.<\/p>\n<p>On return ratios, Cipla\u2019s ROE of 11.83% trails Sun Pharma\u2019s 14.85%, Divi&#8217;s 16.19%, Torrent 26.76%, Zydus 19.69% and Laurus 18.31%. ROCE of 16% is also lower than Sun Pharma\u2019s 19.11%, Divi&#8217;s 21.51%, Torrent 19.27%, Zydus 21.39% and Laurus 18.2%. Its P\/B ratio of 3.17 is lower than all five peers listed in the table.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_Cipla\"><\/span><strong>Why Investors Are Watching Cipla<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li><strong>Today&#8217;s move:<\/strong>&nbsp;the stock fell 2.16% to Rs 1,350.25 from the previous close of Rs 1,380.<\/li>\n<li><strong>Intraday structure:<\/strong>&nbsp;the stock opened at Rs 1,370.05, which was also the day\u2019s high, and slipped near the low of Rs 1,348.95.<\/li>\n<li><strong>Technical position:<\/strong>&nbsp;RSI at 36.94 points to weak momentum, while the price is below the 50 DMA of Rs 1,430.92 and the 200 DMA of Rs 1,381.51.<\/li>\n<li><strong>Fundamental context:<\/strong>&nbsp;P\/E is 33.08, P\/B is 3.17, ROE is 11.83%, ROCE is 16%, EPS is Rs 41.72 and book value is Rs 435.18.<\/li>\n<li><strong>Industry standing:<\/strong>&nbsp;Cipla is a Rs 1,10,515.04 crore Large Cap in Healthcare, with valuation near industry medians but return ratios below several key peers.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"About_Cipla\"><\/span><strong>About Cipla<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Cipla is part of the Healthcare sector and operates within the Pharmaceuticals &amp; Drugs industry. Based on the supplied market data, it is one of the larger listed companies in its industry, with a market capitalisation of Rs 1,10,515.04 crore.<\/p>\n<p>For investors following the company, the key verified context is that it sits in a large listed pharma universe where valuation multiples and return ratios vary sharply across peers. That makes the stock useful to track not only for daily price action, but also for relative valuation and industry positioning.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Track_Cipla_Share_Price_on_Univest\"><\/span><strong>Track Cipla Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use<a href=\"https:\/\/univest.in\/stocks\/cipla\/cipla-ltd-share-price-today\">Cipla (CIPLA) live share-price page<\/a>,<a href=\"https:\/\/univest.in\/screeners\/top-decliners\">Univest top decliners screener<\/a>,<a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a>to review live stock data, top decliners and related market analysis.<\/p>\n<p>On Univest, users can track Cipla Share Price through live market moves, valuation ratios, shareholding pattern updates when available, peer comparisons and broader market insights.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong>&nbsp;Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Why_is_Cipla_Share_Price_falling_today\"><\/span><strong>Why is Cipla Share Price falling today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;Cipla Share Price was down 2.16% at Rs 1,350.25 versus the previous close of Rs 1,380. The supplied data confirms the decline and weak intraday price action, but it does not identify any company-specific catalyst for the move.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Cipla_Share_Price_Today\"><\/span><strong>What is Cipla Share Price Today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;Cipla Share Price Today stood at Rs 1,350.25 at 9:52:59 AM IST on 11 September 2026. That was a fall of Rs 29.75, or 2.16%, from the previous close of Rs 1,380.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_does_todays_price_action_show_for_Cipla\"><\/span><strong>What does today\u2019s price action show for Cipla?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;The stock opened at Rs 1,370.05, which was also the day\u2019s high, and later slipped to Rs 1,348.95. Staying below the previous close through the session points to a weak opening-to-low intraday structure.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Cipla_a_Large_Cap_stock\"><\/span><strong>Is Cipla a Large Cap stock?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;Yes. Cipla is classified as a Large Cap company in the supplied data, with a market capitalisation of Rs 1,10,515.04 crore. That scale is well above the Pharmaceuticals &amp; Drugs industry median market cap of Rs 750.93 crore.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_valuation_ratios_are_investors_tracking_for_Cipla\"><\/span><strong>What valuation ratios are investors tracking for Cipla?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;Investors are tracking a P\/E ratio of 33.08 and a P\/B ratio of 3.17. Against the same-industry benchmark, the P\/E is slightly above the median 32.73, while the P\/B is modestly above the median 3.06.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_profitable_is_Cipla_compared_with_its_industry\"><\/span><strong>How profitable is Cipla compared with its industry?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;Cipla\u2019s ROE is 11.83%, exactly matching the industry median and slightly above the 11.22% average. Its ROCE is 16%, which is stronger than both the industry median of 13.68% and average of 13.71%.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_do_EPS_book_value_and_dividend_yield_show_for_Cipla\"><\/span><strong>What do EPS, book value and dividend yield show for Cipla?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;Cipla\u2019s EPS is Rs 41.72, book value per share is Rs 435.18 and dividend yield is 0.94%. Together, these figures provide context on earnings, accounting net worth per share and historical payout relative to price.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Cipla_compare_with_pharma_peers_on_valuation\"><\/span><strong>How does Cipla compare with pharma peers on valuation?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;Cipla\u2019s P\/E of 33.08 is below Sun Pharma\u2019s 36.98 and far below Divi&#39;s, Torrent and Laurus Labs, which trade above 85. It is, however, above Zydus Lifesciences, which trades at a P\/E of 24.71.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Cipla_compare_with_peers_on_return_ratios\"><\/span><strong>How does Cipla compare with peers on return ratios?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;Cipla\u2019s ROE of 11.83% and ROCE of 16% are lower than the figures shown for Sun Pharma, Divi&#39;s, Torrent, Zydus and Laurus Labs. That suggests a moderate profitability profile within this peer set.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_should_investors_monitor_next_in_Cipla_stock\"><\/span><strong>What should investors monitor next in Cipla stock?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;Investors may watch whether the stock stabilises above the day low of Rs 1,348.95, how it behaves relative to the 200 DMA of Rs 1,381.51 and 50 DMA of Rs 1,430.92, and whether valuation stays near industry norms.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Cipla Share Price falls to Rs 1,350.25. marking a 2.16% fall today. Market cap stands at Rs 1,10,515.04 crore.<\/p>\n","protected":false},"author":29,"featured_media":242963,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-242964","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["242963"],"rank_math_title":["Cipla Share Price Decline: Technical and Fundamental View"],"rank_math_description":["Cipla Share Price fell 2.16% to Rs 1,350.25. Track today's price action, valuation, sector comparison, peer metrics and key levels investors may watch."],"rank_math_focus_keyword":["Cipla Share Price"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/09\/Cipla_CIPLA_Share_Price_Falls_216_Today_as_Stock_Slips_to_Rs_135025_bearish.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/242964","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=242964"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/242964\/revisions"}],"predecessor-version":[{"id":242965,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/242964\/revisions\/242965"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/242963"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=242964"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=242964"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=242964"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}